Our findings that high CYLD levels are predictive for good prognosis in neuroblastoma (Supplementary Figure S4) are in agreement with a recent report showing that higher CYLD expression in neuroblastoma patient samples correlated with better survival and early tumor stages, and CYLD expression was significantly lower in MYCN-amplified tumors [26]. The gene discussed is MYCN; the disease is neuroblastoma.